심장전도장애(레네그레병) 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.2%로 성장할 전망이며, 10억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 부정맥 발생률 증가, 원격 환자 모니터링 채택 확대, 심장 연구 투자 증가, 헬스케어 인프라 확대, 전기 생리학적 치료에 대한 접근성 개선에 의해 견인될 것으로 예측됩니다. 예측 기간 주요 동향으로는 AI를 활용한 진단으로의 시프트, 차세대 페이스메이커의 개발, 심장 치료에 있어서 빅데이터의 통합, 심전도 검사 진보, 원격 의료 서비스 확대 등을 들 수 있습니다.
심장전도장애 유병률 증가는 향후 심장전도장애(레네그레병) 시장의 성장을 가속할 것으로 예측됩니다. 심장 전도 장애는 심장의 전기 신호 전달을 방해하고 부정맥과 심박의 협조 장애를 일으키는 질병입니다. 이러한 질병의 유병률 증가는 심혈관 질환의 이환율 증가 및 인구 고령화와 관련이 있습니다. 고혈압, 관상동맥질환, 심부전 등 심혈관 질환이 만연함에 따라 심장의 전기전도계에 직접 영향을 미치고 부정맥이나 심장 차단 등의 장애를 일으킵니다. 심장전도장애는 전도계를 서서히 변성시켜 폐색이나 부정맥을 일으키는 것으로, 심장전도장애(레네그레병)의 원인이 됩니다. 예를 들어 미국 심장협회의 보고에 따르면 2022년 미국의 심혈관 질환 관련 사망자 수는 94만 1,652명으로 2021년 93만 1,578명에 비해 1만 명 이상 증가했습니다. 따라서 심장전도장애 유병률 증가는 레네그레 병 시장의 성장을 가속하고 있습니다.
심장전도장애(레네그레병) 시장의 기업은 심장 치료의 정확성과 효능을 높이기 위해 고밀도 진단 카테터와 같은 고급 제품의 도입에 주력하고 있습니다. 고밀도 진단 카테터는 심장의 전기적 활동을 고정밀도로 매핑하고 심장 부정맥의 상세한 진단 및 치료를 가능하게 하는 순환기 내과에 사용되는 특수 의료기기입니다. 예를 들어, 미국의 의료기기 제조업체인 바이오센스웹스터사는 2023년 7월, TRUEref 기술을 탑재한 매핑 카테터 'OPTRELL'을 발매했습니다. 이 카테터는 CARTO 3 시스템을 탑재하여 48개의 작은 전극으로 고화질 전기생리학적 매핑을 수행하여 임상의가 복잡한 부정맥을 보다 정확하게 매핑하고 보다 효과적인 절제 전략을 개발할 수 있도록 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 심장전도장애(레네그레병) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 심장전도장애(레네그레병) 시장 : 성장률 분석
- 세계의 심장전도장애(레네그레병) 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 심장전도장애(레네그레병) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 심장전도장애(레네그레병) 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 심장전도장애(레네그레병) 시장 : 장애 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 피부 레네그레병
- 전신성 레네그레병
- 세계의 심장전도장애(레네그레병) 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 코르티코스테로이드
- 면역억제제
- 생물학적 요법
- 광선요법
- 기타 치료법
- 세계의 심장전도장애(레네그레병) 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 피부과 클리닉
- 외래수술센터(ASC)
- 기타 최종 사용자
- 세계의 심장전도장애(레네그레병) 시장 : 피부 심장전도장애(레네그레병) 병형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 자가면역 관련 피부 심장전도장애(레네그레병)
- 유전성 피부 심장전도장애(레네그레병)
- 특발성 피부 질환 심장전도장애(레네그레병)
- 약제 유발성 피부 심장전도장애(레네그레병)
- 세계의 심장전도장애(레네그레병) 시장 : 전신성 심장전도장애(레네그레병) 병형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 주요 시스템 심장전도장애(레네그레병)
- 2차 시스템 심장전도장애(레네그레병)
- 선천성 전신성 심장전도장애(레네그레병)
- 노화와 관련된 전신적 심장전도장애(레네그레병)
제7장 지역별 및 국가별 분석
- 세계의 심장전도장애(레네그레병) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 심장전도장애(레네그레병) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 심장전도장애(레네그레병) 시장 : 경쟁 구도
- 심장전도장애(레네그레병) 시장 : 기업 프로파일
- Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
- Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- AstraZeneca PLC
- Abbott Laboratories
- Novartis AG
- Medtronic plc
- Eli Lilly and Company
- Amgen Inc.
- Intas Pharmaceuticals Ltd.
- Boston Scientific Corporation
- Dr. Reddy's Laboratories Ltd.
- Hikma Pharmaceuticals PLC
- Biotronik SE & Co. KG
- LivaNova PLC
- Lepu Medical Technology(Beijing) Co. Ltd.
- Osypka AG
- Medico SRL
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 심장전도장애(레네그레병) 시장(2029년) : 새로운 기회를 제공하는 국가
- 심장전도장애(레네그레병) 시장(2029년) : 새로운 기회를 제공하는 부문
- 심장전도장애(레네그레병) 시장(2029년) : 성장 전략
제36장 부록
AJY
Lenegre's disease is a rare condition that primarily affects the heart's electrical conduction system, leading to arrhythmia. It is characterized by the progressive development of fibrosis (scarring) in the cardiac conduction tissues, including the atrioventricular (AV) node and the bundle of His, which can disrupt the heart's ability to transmit electrical impulses properly.
The primary types of Lenegre's disease are cutaneous Lenegre's disease and systemic Lenegre's disease. Cutaneous Lenegre's disease is a skin disorder characterized by progressive scarring and thickening of the skin, leading to noticeable changes in texture and appearance. Treatment options include corticosteroids, immunosuppressants, biological therapies, phototherapy, and others. These treatments are typically administered in hospitals, dermatology clinics, ambulatory surgical centers, and other healthcare settings.
The lenegre's disease market research report is one of a series of new reports from The Business Research Company that provides lenegre's disease market statistics, including the lenegre's disease industry's global market size, regional shares, competitors with a lenegre's disease market share, detailed lenegre's disease market segments, market trends and opportunities, and any further data you may need to thrive in the lenegre's disease industry. This lenegre's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lenegre's disease market size has grown strongly in recent years. It will grow from $0.72 billion in 2024 to $0.77 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth observed during the historical period can be attributed to factors such as the rising prevalence of cardiovascular diseases, an aging population, greater awareness of conduction disorders, increased healthcare spending, and initiatives for early diagnosis.
The lenegre's disease market size is expected to see strong growth in the next few years. It will grow to $1.02 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period is expected to be driven by the increasing incidence of arrhythmias, greater adoption of remote patient monitoring, rising investment in cardiac research, expansion of healthcare infrastructure, and improved access to electrophysiology treatments. Key trends for the forecast period include a shift toward AI-driven diagnostics, the development of next-generation pacemakers, the integration of big data in cardiac care, advancements in electrocardiography, and the expansion of telehealth services.
The rising prevalence of cardiac conduction disorders is expected to drive the growth of the Lenegre disease market in the future. Cardiac conduction disorders are conditions that disrupt the heart's electrical signaling, leading to irregular heart rhythms or impaired coordination of heartbeats. The increasing prevalence of these disorders is linked to the rising incidence of cardiovascular diseases and the aging population. As cardiovascular conditions such as hypertension, coronary artery disease, and heart failure become more widespread, they directly affect the heart's electrical conduction system, leading to disorders such as arrhythmias and heart block. Cardiac conduction disorders contribute to Lenegre's disease by progressively degenerating the conduction system, causing blockages and arrhythmias. For example, the American Heart Association reported that in 2022, the U.S. saw 941,652 cardiovascular disease-related deaths, an increase of more than 10,000 compared to the 931,578 deaths in 2021. Therefore, the increasing prevalence of cardiac conduction disorders is fueling the growth of the Lenegre disease market.
Companies in the Lenegre disease market are focusing on introducing advanced products, such as high-density diagnostic catheters, to enhance the accuracy and effectiveness of cardiac procedures. High-density diagnostic catheters are specialized medical devices used in cardiology to map the electrical activity of the heart with high precision, allowing for detailed diagnosis and treatment of cardiac arrhythmias. For instance, in July 2023, Biosense Webster Inc., a U.S.-based medical equipment company, launched the OPTRELL mapping catheter with TRUEref technology. This catheter, powered by the CARTO 3 System, provides high-definition electrophysiological mapping with 48 small electrodes, enabling clinicians to map complex cardiac arrhythmias more precisely and develop more effective ablation strategies.
In August 2022, Medtronic Plc, a U.S.-based medical technology company, acquired Affera Inc. for $925 million. The acquisition aims to enhance and expand Medtronic's cardiac ablation portfolio, particularly by integrating advanced cardiac mapping and navigation technologies to improve treatments for patients with cardiac arrhythmias. Affera Inc. is a U.S.-based company that develops advanced cardiac mapping and ablation technologies for treating arrhythmias.
Major players in the lenegre's disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Intas Pharmaceuticals Ltd., Boston Scientific Corporation, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Biotronik SE & Co. KG, LivaNova PLC, Lepu Medical Technology (Beijing) Co. Ltd., Osypka AG, Medico S.R.L.
North America was the largest region in the lenegre's disease market in 2024. The regions covered in lenegre's disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the lenegre's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lenegre's disease market consists of revenues earned by entities providing services such as diagnostic services, pacemaker implantation, electrophysiology studies, cardiac monitoring, and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The lenegre's disease market also includes sales of pacemakers, holter monitors, electrophysiology catheters, and cardiac diagnostic software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lenegre's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lenegre's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lenegre's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lenegre's disease market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Disorder Type: Cutaneous Lenegres Disease; Systemic Lenegres Disease
- 2) By Treatment: Corticosteroids; Immunosuppressants; Biological Therapies; Phototherapy; Other Treatments
- 3) By End User: Hospital; Dermatology Clinics; Ambulatory Surgical Centers; Other End Users
- Subsegments:
- 1) By Cutaneous Lenegre's Disease: Autoimmune-Related Cutaneous Lenegre's Disease; Genetic Cutaneous Lenegre's Disease; Idiopathic Cutaneous Lenegre's Disease; Drug-Induced Cutaneous Lenegre's Disease
- 2) By Systemic Lenegre's Disease: Primary Systemic Lenegre's Disease; Secondary Systemic Lenegre's Disease; Congenital Systemic Lenegre's Disease; Aging-related Systemic Lenegre's Disease
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lenegre's Disease Market Characteristics
3. Lenegre's Disease Market Trends And Strategies
4. Lenegre's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Lenegre's Disease Growth Analysis And Strategic Analysis Framework
- 5.1. Global Lenegre's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Lenegre's Disease Market Growth Rate Analysis
- 5.4. Global Lenegre's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Lenegre's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Lenegre's Disease Total Addressable Market (TAM)
6. Lenegre's Disease Market Segmentation
- 6.1. Global Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cutaneous Lenegres Disease
- Systemic Lenegres Disease
- 6.2. Global Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids
- Immunosuppressants
- Biological Therapies
- Phototherapy
- Other Treatments
- 6.3. Global Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Dermatology Clinics
- Ambulatory Surgical Centers
- Other End Users
- 6.4. Global Lenegre's Disease Market, Sub-Segmentation Of Cutaneous Lenegre's Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autoimmune-Related Cutaneous Lenegre's Disease
- Genetic Cutaneous Lenegre's Disease
- Idiopathic Cutaneous Lenegre's Disease
- Drug-Induced Cutaneous Lenegre's Disease
- 6.5. Global Lenegre's Disease Market, Sub-Segmentation Of Systemic Lenegre's Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Systemic Lenegre's Disease
- Secondary Systemic Lenegre's Disease
- Congenital Systemic Lenegre's Disease
- Aging-related Systemic Lenegre's Disease
7. Lenegre's Disease Market Regional And Country Analysis
- 7.1. Global Lenegre's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Lenegre's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Lenegre's Disease Market
- 8.1. Asia-Pacific Lenegre's Disease Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lenegre's Disease Market
- 9.1. China Lenegre's Disease Market Overview
- 9.2. China Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lenegre's Disease Market
- 10.1. India Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lenegre's Disease Market
- 11.1. Japan Lenegre's Disease Market Overview
- 11.2. Japan Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lenegre's Disease Market
- 12.1. Australia Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lenegre's Disease Market
- 13.1. Indonesia Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lenegre's Disease Market
- 14.1. South Korea Lenegre's Disease Market Overview
- 14.2. South Korea Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lenegre's Disease Market
- 15.1. Western Europe Lenegre's Disease Market Overview
- 15.2. Western Europe Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lenegre's Disease Market
- 16.1. UK Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lenegre's Disease Market
- 17.1. Germany Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lenegre's Disease Market
- 18.1. France Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lenegre's Disease Market
- 19.1. Italy Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lenegre's Disease Market
- 20.1. Spain Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lenegre's Disease Market
- 21.1. Eastern Europe Lenegre's Disease Market Overview
- 21.2. Eastern Europe Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lenegre's Disease Market
- 22.1. Russia Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lenegre's Disease Market
- 23.1. North America Lenegre's Disease Market Overview
- 23.2. North America Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lenegre's Disease Market
- 24.1. USA Lenegre's Disease Market Overview
- 24.2. USA Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lenegre's Disease Market
- 25.1. Canada Lenegre's Disease Market Overview
- 25.2. Canada Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lenegre's Disease Market
- 26.1. South America Lenegre's Disease Market Overview
- 26.2. South America Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lenegre's Disease Market
- 27.1. Brazil Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lenegre's Disease Market
- 28.1. Middle East Lenegre's Disease Market Overview
- 28.2. Middle East Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lenegre's Disease Market
- 29.1. Africa Lenegre's Disease Market Overview
- 29.2. Africa Lenegre's Disease Market, Segmentation By Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Lenegre's Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Lenegre's Disease Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lenegre's Disease Market Competitive Landscape And Company Profiles
- 30.1. Lenegre's Disease Market Competitive Landscape
- 30.2. Lenegre's Disease Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Lenegre's Disease Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Abbott Laboratories
- 31.3. Novartis AG
- 31.4. Medtronic plc
- 31.5. Eli Lilly and Company
- 31.6. Amgen Inc.
- 31.7. Intas Pharmaceuticals Ltd.
- 31.8. Boston Scientific Corporation
- 31.9. Dr. Reddy's Laboratories Ltd.
- 31.10. Hikma Pharmaceuticals PLC
- 31.11. Biotronik SE & Co. KG
- 31.12. LivaNova PLC
- 31.13. Lepu Medical Technology (Beijing) Co. Ltd.
- 31.14. Osypka AG
- 31.15. Medico S.R.L.
32. Global Lenegre's Disease Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Lenegre's Disease Market
34. Recent Developments In The Lenegre's Disease Market
35. Lenegre's Disease Market High Potential Countries, Segments and Strategies
- 35.1 Lenegre's Disease Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Lenegre's Disease Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Lenegre's Disease Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
